To access archived issues of IAVI Report dating back to 1996, click here.
Subscribe below to receive IAVI Report right to your inbox.
Questions/comments? Email us at firstname.lastname@example.org.
Upending the dogma of TB latency: Will it offer new clues for vaccine research?
February 14, 2024
Nearly 150 years after the discovery of tuberculosis, researchers are still unraveling the fundamental biology and epidemiology of the germ and how best to defeat it.
Will AI crack the code for antigens?
November 30, 2023
The scientific implications of artificial intelligence loom large. One tangible application is designing better vaccines.
Marion Gruber, Changemaker
November 9, 2023
After more than three decades at the U.S. Food and Drug Administration, Gruber is continuing her legacy of changing the way vaccines are licensed and distributed.
Painstaking progress in African vaccine manufacturing
October 31, 2023
Improving vaccine access topped the agenda at a major public health gathering in Berlin, where pandemic preparedness loomed large.
It takes a village
October 4, 2023
Exploring potential synergies between B- and T-cell HIV vaccine strategies is a priority for the field given results from recent trials.
Hitchhiking the mucosa
July 6, 2023
Brittany Hartwell and her lab are exploring new ways to transport vaccine antigens across mucosal barriers to trigger more protective immune responses against many pathogens, including HIV.
Powering up African-based data centers
June 22, 2023
COVID-19 illustrated once again the importance of localized epidemiological data, monitoring, and analysis.
COVID-19 is no longer an emergency, but its lessons better linger
May 24, 2023
Two new books illustrate why reflection and preparation are both essential to ensure a quicker and more equitable response to the next pandemic.
Keeping it all in perspective
May 9, 2023
A view from Zambia on the shifting landscape of HIV vaccine research and the enduring optimism that characterizes one researcher’s drive.
What will it take to improve access to vaccines?
April 13, 2023
Work is underway but obstacles to vaccine procurement and delivery for the next pandemic loom large.
RSV vaccines: the latest success story
March 14, 2023
After decades of research, structure-based design efforts are yielding effective vaccines against respiratory syncytial virus. Jason McLellan explains the breakthroughs that paved the way.